Remedy Technologies develops AI agents that automate pharmacy workflows, manage prescription refills, and handle insurance and billing.
Remedy Technologies has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2025.
Remedy Technologies's investors include Y Combinator.
Remedy Technologies is headquartered in Austin, United States.
Remedy Technologies develops AI agents that automate pharmacy workflows, manage prescription refills, and handle insurance and billing.
Remedy Technologies is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Remedy Technologies — Funding & Investors." VCBacked, September 5, 2025, https://www.vcbacked.co/company/remedy-technologies. Accessed November 12, 2026.
VCBacked. (2025). Remedy Technologies — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/remedy-technologies
{{cite web |title=Remedy Technologies — Funding & Investors |url=https://www.vcbacked.co/company/remedy-technologies |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Remedy Technologies? Request a listing update